Skip to main content
Clinical Trials/ISRCTN99048944
ISRCTN99048944
Completed
未知

The feasibility of a randomised controlled trial of dietary and physical activity interventions for men with localised prostate cancer: the PrEvENT trial

niversity of Bristol (UK)0 sites108 target enrollmentNovember 17, 2014

Overview

Phase
未知
Intervention
Not specified
Conditions
Prostate cancer
Sponsor
niversity of Bristol (UK)
Enrollment
108
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

2016 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/26948468 protocol 2017 Results article in https://www.ncbi.nlm.nih.gov/pubmed/28264695 results 2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/31699723 results (added 11/11/2019)

Registry
who.int
Start Date
November 17, 2014
End Date
August 1, 2016
Last Updated
4 years ago
Study Type
Interventional
Sex
Male

Investigators

Sponsor
niversity of Bristol (UK)

Eligibility Criteria

Inclusion Criteria

  • 1\. Localised prostate cancer
  • 2\. To be undergoing radical prostatectomy
  • 3\. Be due to receive treatment at the Urology Centre, Southmead Hopsital, North Bristol NHS Trust
  • 4\. Capacity to consent for themselves as judged by a member of the research team with appropriate training and experience
  • 5\. Be aged 18 or over, there is no upper age limit
  • 6\. Have sufficient understanding of the English language, including being able to read and speak English at a basic level

Exclusion Criteria

  • 1\. Inability to give informed consent or unavailability for follow\-up
  • 2\. Being identified as unsuitable to participate following guidance of their clinician
  • 3\. Co\-morbidities which could prevent participation in the intervention (RCT only) ie. this could include uncontrolled congestive heart failure or angina, recent myocardial infarction or breathing difficulties requiring oxygen use or hospitalisation. Additionally, the use of a mobility aid other than a walking stick
  • 4\. Allergies which would prevent participation in the intervention (RCT only) ie. allergy to lycopene
  • 5\. Religious beliefs that constrain them from participating in any aspect of the intervention (RCT only)
  • 6\. Any other additional reason for not being able to participate in any aspect of the intervention (RCT only)
  • 7\. Current heavy consumers of the nutritional element of the intervention, as judged by the research team (RCT only) ie. those who have been taking lycopene supplements daily for more than three months or eat more than five portions of fruit and vegetables every single day
  • 8\. Those who routinely exercise vigorously may not be suitable for the intervention (RCT only)

Outcomes

Primary Outcomes

Not specified

Similar Trials